Chan YM - Search Results

1

The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients.

Fong DY, Lee AH, Tung SY, Wong JY, Chan YM, Goh CR, Cheung YB. Fong DY, et al. Among authors: chan ym. Qual Life Res. 2014 Feb;23(1):311-6. doi: 10.1007/s11136-013-0456-z. Epub 2013 Jun 18. Qual Life Res. 2014. PMID: 23775604

2

Effect of individual psychological intervention in Chinese women with gynecologic malignancy: a randomized controlled trial.

Chan YM, Lee PW, Fong DY, Fung AS, Wu LY, Choi AY, Ng TY, Ngan HY, Wong LC. Chan YM, et al. J Clin Oncol. 2005 Aug 1;23(22):4913-24. doi: 10.1200/JCO.2005.02.069. Epub 2005 Jun 6. J Clin Oncol. 2005. PMID: 15939927 Clinical Trial.

3

A longitudinal study on quality of life after gynecologic cancer treatment.

Chan YM, Ngan HY, Li BY, Yip AM, Ng TY, Lee PW, Yip PS, Wong LC. Chan YM, et al. Gynecol Oncol. 2001 Oct;83(1):10-9. doi: 10.1006/gyno.2001.6345. Gynecol Oncol. 2001. PMID: 11585408

4

The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.

Chan YM, Leung TN, Leung TY, Fung TY, Chan LW, Lau TK. Chan YM, et al. Among authors: chan lw. Prenat Diagn. 2006 Sep;26(9):819-24. doi: 10.1002/pd.1511. Prenat Diagn. 2006. PMID: 16832829

5

Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with topotecan.

Tam KF, Chan YM, Ng TY, Wong LC, Ngan HY. Tam KF, et al. Among authors: chan ym. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):135-9. doi: 10.1111/j.1525-1438.2006.00295.x. Int J Gynecol Cancer. 2006. PMID: 16445623

6

Acceptance towards giving birth to a child with beta-thalassemia major - A prospective study.

Chan YM, Chan OK, Cheng YKY, Leung TY, Lao TTH, Sahota DS. Chan YM, et al. Among authors: chan ok. Taiwan J Obstet Gynecol. 2017 Oct;56(5):618-621. doi: 10.1016/j.tjog.2017.08.007. Taiwan J Obstet Gynecol. 2017. PMID: 29037546 Free article.

7

Women's uptake of non-invasive DNA testing following a high-risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review.

Chan YM, Leung WC, Chan WP, Leung TY, Cheng YK, Sahota DS. Chan YM, et al. Among authors: chan wp. Prenat Diagn. 2015 Apr;35(4):342-7. doi: 10.1002/pd.4544. Epub 2015 Jan 4. Prenat Diagn. 2015. PMID: 25484032

8

Impact of replacing Chinese ethnicity-specific fetal biometry charts with the INTERGROWTH-21(st) standard.

Cheng Y, Leung TY, Lao T, Chan YM, Sahota DS. Cheng Y, et al. Among authors: chan ym. BJOG. 2016 Sep;123 Suppl 3:48-55. doi: 10.1111/1471-0528.14008. BJOG. 2016. PMID: 27627597

9

Chinese women's preferences for prenatal diagnostic procedure and their willingness to trade between procedures.

Chan YM, Sahota DS, Leung TY, Choy KW, Chan OK, Lau TK. Chan YM, et al. Among authors: chan ok. Prenat Diagn. 2009 Dec;29(13):1270-6. doi: 10.1002/pd.2394. Prenat Diagn. 2009. PMID: 19862769

10

A survey of prenatal first-trimester aneuploidy screening among Hong Kong specialist obstetricians.

Chan YM, Sahota DS, Chan OK, Leung TY, Lau TK. Chan YM, et al. Among authors: chan ok. Hong Kong Med J. 2009 Dec;15(6):447-51. Hong Kong Med J. 2009. PMID: 19966349 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters